Imperial's 30% share of revenue from the Red Chris mine in 2024 was $190.0 million compared to $109.8 million in 2023, an ...

The FDA has completed its review of the investigational new drug application (IND) for PSV359, and issued a "study may proceed” letter in 1Q 2025. Site activation activities are underway, with the ...

Market analysts see strong tailwinds for Canadian small-cap stocks in 2025, especially three high-quality companies. The post ...

Adding to the bad vibes, the outlook for the stock market slid sharply, and just 37.4% of respondents said they expected ...